Pharvaris
PHVS
22 hedge funds and large institutions have $321M invested in Pharvaris in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 4 closing their positions.
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
0.05% more ownership
Funds ownership: 65.29% → 65.34% (+0.05%)
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
12% less funds holding
Funds holding: 25 → 22 (-3)
16% less capital invested
Capital invested by funds: $380M → $321M (-$59.2M)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Suvretta Capital Management
New York
|
+$12.9M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
+$1.52M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$999K |
| 4 |
Goldman Sachs
New York
|
+$427K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
+$25.7K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VA
VR Adviser
New York
|
-$9.8M |
| 2 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
-$5.15M |
| 3 |
Millennium Management
New York
|
-$596K |
| 4 |
DM
Deerfield Management
New York
|
-$424K |
| 5 |
CLOS
Compagnie Lombard Odier SCmA
1204 Geneva,
Switzerland
|
-$287K |
PHVS Hedge Fund Activity: Q4 2021 in Review
22 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Pharvaris (PHVS) for Q4 2021, worth a combined $321M — down 16% from $380M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of PHVS and 1 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 6 added.
The largest buyer was Suvretta Capital Management, opening a new position worth an estimated $12.9M. The largest seller was VR Adviser, exiting entirely with an estimated $9.8M sold.
- 22 institutional investors held Pharvaris (PHVS) as of Q4 2021, down from 25 in Q3 2021.
- Funds reported $321M of Pharvaris stock for Q4 2021, down 16% quarter-over-quarter.
- 1 fund opened new Pharvaris positions in Q4 2021 and 4 closed out, a net change of -3 holders.
- The largest Pharvaris buyer in Q4 2021 was Suvretta Capital Management, an estimated $12.9M added.
- The largest Pharvaris seller in Q4 2021 was VR Adviser, an estimated $9.8M sold.
Based on aggregated 13F filings for Q4 2021.